Please provide your email address to receive an email when new articles are posted on . Belzupacap sarotalocan via suprachoroidal administration demonstrated positive interim phase 2 safety and ...

Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are the leading causes of vision impairment in elderly patients and people living with diabetes, respectively.

Please provide your email address to receive an email when new articles are posted on . Aura Biosciences has reached an agreement with the FDA for a study design investigating belzupacap sarotalocan ...

Bel-sar is currently in development for ocular cancers, and Aura has initiated activities for the global Phase 3 trial evaluating first-line treatment of early-stage choroidal melanoma, a vision- and ...